News and Comments


  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...

Recent Postings



Exelixis (EXEL) Amgen (AMGN) MODERNA Vitae Pharmaceuticals (VTAE) Advaxis (ADXS) GUARDIAN HEALTH Illumina (ILMN) Spike Therapeutics (ONCE) Zerenex Telaprevir ACADIA (ACAD) ADVENTRIX (ANX) Dynavax (DVAX) Alnylam (ALNY) AERIE PHARMACEUTICALS Human Genome Sciences (HGSI) Ionis (IONS) C4 Therapeutics Genentech OSI (OSIP) ZALTRAP™ Herceptin ABBVIE (ABBV) Aimmune Therapeutics (AIMT) galapagos (GLPG) Incyte (INCY) Intrexon (XON) Ziofpharm (ZIOP) Seattle Genetics (SGEN) Ariad (ARIA) Bristol-Myers Squibb (BMY) SYNTA (SNTA) VANDA (VNDA) Intermune (ITMN) Adaptimmune (ADAP) Agenus (AGEN Sequenom (SQNM) BIOMARIN (BMRN) Intercept (ICPT) Theravance (THRX) CompuGen (CGEN) Jazz Pharmaceuticals (JAZZ) NOVOCURE (NVCR) ISIS (ISIS) Abbott Laboratories (ABT) Biocryst (BCRX) Merck (MRK) Array Pharmaceuticals (ARRY) Biogen Idec (BIIB) Pluristem (PSTI) IDERA (IDRA) PTC Therapeutics (PTCT) Endometrial Cancer Global Cell Therapeutics (GBT) Benlysta (belimumab) Vertex (VRTX) Theravance Bio Pharma (TBPH) Mirati Therapeutics (MRTX) Valeant Pharmaceuticals International (VRX) Editas (EDIT) GlaxoSmithKline (GSK) TOKAI (TKAOI) Sangamo (SGMO) Rapamune KITE (KITE) ARGOS (ARGS) Elan (ELN) AGOS (ARGS) Sanofi-Aventis (SAN) Galena (GALE) Xoma (XOMA) SUNESIS PHARMACEUTICALS (SNSS) Onyx (ONXX) Revlimid (lenolidamide) ARCA (ABIO) NEKTAR (NKTR)) Roche (ROCHE) Prolor Biotech (PBTH) Cytokinetics (CYTK) Bellicum (BLCM) Anadys (ANDS) ImmunoGen (IMGN) Velcade (bortezomib) Anacor (ANAC) Dendreon (DNDN) Regeneron (REGN) Roche (RHHBY) KERYX (KERX) Human Longevity (HLI) AstraZeneca (AZN) SERES THERAPEUTICS (MCRB) Trastuzumab-DM1 Auspex (ASPX) JUNO (JUNO) Sarepta (SRPT) NANTKWEST (NK) Agenus (AGEN) Ridaforolimus Idenix (IDIX) Gilead (GILD) Prosensa (RNA) Tysabri REGULUS (RGLS) Alder Biopharmaceuticals (ALDR) Micromet (MITI) Sanofi (SNA) RenenxBio (RGNX) INNOVIVA (INVA) Sanofi (SNY) HALOZYME (HALO) Inovio (INO) Multiple Myeloma